|Buyback Dates||27 Apr 2021 - 10 May 2021|
|Record Date||01 Apr 2021|
|Approval Date||19 Mar 2021|
|Public Announcement||19 Mar 2021|
|Buyback Offer||Rs.60.00 crores|
|Buyback Offer Size||9.82%|
|Number of Shares||600000|
|Buyback Type||Tender Offer|
Aarti Drugs Ltd. was established in the year 1984 and forms part of $900 Million Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations.
The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited.
Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.
Over the years, the Company has been able to carve a niche for itself and is looking forward to expand the volumes. With the government initiative to encourage private health insurance schemes, consumer spending on medicines is expected to increase, which will spur growth in the generic sector in the domestic market.
The manufacturing-units of Aarti Drugs Ltd. are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved.
The Company aims at becoming the first choice of this expanding market through better products, ensuring quality and timely delivery.
Entitlement Ratio of Buyback for Reserved Category for Small Shareholders is 8 Equity Shares out of every 569 fully paid-up Equity Shares held on the Record Date and
5 Equity Shares out of every 851 Equity Shares held on the Record Date for General Category for all other Eligible Shareholders
The Record Date for Aarti Drugs Limited Buyback is 01 Apr 2021.
The Aarti Drugs Limited Buyback will open on 27 Apr 2021 and closes on 10 May 2021.
The Buyback price of Aarti Drugs Limited is Rs.1000.
The Buyback Type of Aarti Drugs Limited is Tender Offer.